The commission shall:
(1) monitor and analyze Medicaid prescription drug use and expenditure patterns;
(2) identify the therapeutic prescription drug classes and individual prescription drugs that are most often prescribed to patients or that represent the greatest expenditures; and
(3) post the data the commission identifies under this section on the commission’s Internet website and update the information on a quarterly basis.

Text of section effective on April 01, 2025